- Home
- PLUR vs WNW Comparison
PLUR vs WNW Comparison
Compare PLUR & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLUR | WNW |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4M | 25.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PLUR | WNW |
|---|---|---|
| Price | $3.31 | $1.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 9.9K | ★ 33.5K |
| Earning Date | 02-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | $1,326,000.00 | ★ $2,550,178.00 |
| Revenue This Year | $97.38 | N/A |
| Revenue Next Year | $293.97 | N/A |
| P/E Ratio | ★ N/A | $1.34 |
| Revenue Growth | 121.74 | ★ 570.49 |
| 52 Week Low | $2.82 | $0.95 |
| 52 Week High | $7.13 | $6.66 |
Technical Indicators
Market Signals| Indicator | PLUR | WNW |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 55.09 |
| Support Level | $3.00 | $1.40 |
| Resistance Level | $3.50 | $1.79 |
| Average True Range (ATR) | 0.16 | 0.15 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 65.00 | 63.92 |
Price Performance
Historical ComparisonAbout PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.